View Daily Data Tracking History
View Bill Text
View Amendment
View Engrossed Bill (Original Bill with Amendment(s) Incorporated)
View Statement of Purpose / Fiscal Impact
H0213aa...............................................by HEALTH AND WELFARE
RITALIN - Adds to existing law to require pharmacies that dispense Ritalin
shall disclose to the person taking possession of the dispensed
prescription, of the known side effects of the prescriptive and
nonprescriptive use of the drug and other consequences; to direct the Board
of Pharmacy to promulgate rules to ensure that the disclosed information is
provided by the dispensing pharmacy to each person who takes possession of
a prescription for Ritalin and that specified information is consistent
with the most current medical findings.
02/13 House intro - 1st rdg - to printing
02/14 Rpt prt - to Health/Wel
02/27 Rpt out - to Gen Ord
02/28 Rpt out amen - to engros
03/01 Rpt engros - 1st rdg - to 2nd rdg as amen
03/02 2nd rdg - to 3rd rdg as amen
03/05 3rd rdg as amen - PASSED - 52-10-8
AYES -- Barraclough(Barraclough), Barrett, Bedke, Bell, Black, Bolz,
Bradford, Bruneel, Callister, Campbell, Chase, Clark, Collins, Crow,
Cuddy, Deal, Denney, Ellis, Ellsworth, Field(20), Gagner, Gould,
Hadley, Hammond, Harwood, Higgins, Hornbeck, Jones, Kellogg, Kunz,
Lake, Langford, Loertscher, Mader, McKague, Meyer, Mortensen, Moss,
Moyle, Pearce, Pischner, Roberts, Sali, Schaefer, Smith, Smylie,
Stone, Swan(Hansen), Tilman, Trail, Young, Mr. Speaker
NAYS -- Bieter, Boe, Jaquet, Kendell, Marley, Pomeroy, Ridinger,
Robison, Sellman, Shepherd.
Absent and excused -- Eskridge, Field(13), Henbest, Montgomery,
Raybould, Stevenson, Wheeler, Wood
Floor Sponsor -- Campbell
Title apvd - to Senate
03/06 Senate intro - 1st rdg - to Health/Wel
|||| LEGISLATURE OF THE STATE OF IDAHO ||||
Fifty-sixth Legislature First Regular Session - 2001
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 213
BY HEALTH AND WELFARE COMMITTEE
1 AN ACT
2 RELATING TO UNIFORM CONTROLLED SUBSTANCES; AMENDING CHAPTER 27, TITLE 37,
3 IDAHO CODE, BY THE ADDITION OF A NEW SECTION 37-2731A, IDAHO CODE, TO
4 REQUIRE THAT PHARMACISTS DISPENSING RITALIN SHALL DISCLOSE TO THE PERSON
5 TAKING POSSESSION OF THE DISPENSED PRESCRIPTION KNOWN SIDE EFFECTS OF
6 PRESCRIPTIVE AND NONPRESCRIPTIVE USE OF THE DRUG AND OTHER CONSEQUENCES,
7 AND TO DIRECT THE BOARD OF PHARMACY TO PROMULGATE RULES TO ENSURE THAT THE
8 DISCLOSED INFORMATION IS PROVIDED BY THE DISPENSING PHARMACIST TO EACH
9 PERSON WHO TAKES POSSESSION OF A RITALIN PRESCRIPTION AND THAT SPECIFIED
10 INFORMATION IS CONSISTENT WITH THE MOST CURRENT MEDICAL FINDINGS.
11 Be It Enacted by the Legislature of the State of Idaho:
12 SECTION 1. That Chapter 27, Title 37, Idaho Code, be, and the same is
13 hereby amended by the addition thereto of a NEW SECTION, to be known and des-
14 ignated as Section 37-2731A, Idaho Code, and to read as follows:
15 37-2731A. DISCLOSURE ON DISPENSING RITALIN. (1) Any pharmacist as
16 defined in section 54-1705(22), Idaho Code, who dispenses the stimulant
17 methylphenidate, commonly known as ritalin, shall disclose, at the least, the
18 following information:
19 (a) Known side effects of prescriptive use of the drug include
20 tachycardia, dizziness, insomnia, depression, abdominal pain, anorexia,
21 loss of appetite, dry mouth and suppression of growth has been associated
22 with long-term use;
23 (b) Ingesting the tablet by any means other than swallowing can result in
24 severe reactions or complications such as blood clots, skin and circula-
25 tory problems, and even death; and
26 (c) No person who takes ritalin after the age of twelve (12) years is
27 eligible for military service.
28 (d) Distribution of the medication to any other person is a felony
29 offense in Idaho and is also a federal offense.
30 (2) The board is authorized and directed to promulgate rules to ensure
31 that the information in subsection (1) of this section is provided by the dis-
32 pensing pharmacist to each person who takes possession of a ritalin prescrip-
33 tion. In addition, the board is responsible for ensuring that the information
34 provided by the dispensing pharmacist is consistent with the most current med-
35 ical findings.
|||| LEGISLATURE OF THE STATE OF IDAHO ||||
Fifty-sixth Legislature First Regular Session - 2001
Moved by Sali
Seconded by Campbell
IN THE HOUSE OF REPRESENTATIVES
HOUSE AMENDMENT TO H.B. NO. 213
1 AMENDMENTS TO SECTION 1
2 On page 1 of the printed bill, in lines 15 and 16, delete "pharmacist as
3 defined in section 54-1705(22), Idaho Code, who" and insert: "pharmacy
4 licensed by the board that"; in lines 31 and 32, delete "dispensing pharma-
5 cist" and insert: "licensed dispensing pharmacy"; and in line 34, delete
6 "dispensing pharmacist" and insert: "licensed dispensing pharmacy".
7 CORRECTION TO TITLE
8 On page 1, in line 8, delete "DISPENSING PHARMACIST" and insert: "LICENSED
9 DISPENSING PHARMACY".
|||| LEGISLATURE OF THE STATE OF IDAHO ||||
Fifty-sixth Legislature First Regular Session - 2001
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 213, As Amended
BY HEALTH AND WELFARE COMMITTEE
1 AN ACT
2 RELATING TO UNIFORM CONTROLLED SUBSTANCES; AMENDING CHAPTER 27, TITLE 37,
3 IDAHO CODE, BY THE ADDITION OF A NEW SECTION 37-2731A, IDAHO CODE, TO
4 REQUIRE THAT PHARMACISTS DISPENSING RITALIN SHALL DISCLOSE TO THE PERSON
5 TAKING POSSESSION OF THE DISPENSED PRESCRIPTION KNOWN SIDE EFFECTS OF
6 PRESCRIPTIVE AND NONPRESCRIPTIVE USE OF THE DRUG AND OTHER CONSEQUENCES,
7 AND TO DIRECT THE BOARD OF PHARMACY TO PROMULGATE RULES TO ENSURE THAT THE
8 DISCLOSED INFORMATION IS PROVIDED BY THE LICENSED DISPENSING PHARMACY TO
9 EACH PERSON WHO TAKES POSSESSION OF A RITALIN PRESCRIPTION AND THAT SPECI-
10 FIED INFORMATION IS CONSISTENT WITH THE MOST CURRENT MEDICAL FINDINGS.
11 Be It Enacted by the Legislature of the State of Idaho:
12 SECTION 1. That Chapter 27, Title 37, Idaho Code, be, and the same is
13 hereby amended by the addition thereto of a NEW SECTION, to be known and des-
14 ignated as Section 37-2731A, Idaho Code, and to read as follows:
15 37-2731A. DISCLOSURE ON DISPENSING RITALIN. (1) Any pharmacy licensed by
16 the board that dispenses the stimulant methylphenidate, commonly known as
17 ritalin, shall disclose, at the least, the following information:
18 (a) Known side effects of prescriptive use of the drug include
19 tachycardia, dizziness, insomnia, depression, abdominal pain, anorexia,
20 loss of appetite, dry mouth and suppression of growth has been associated
21 with long-term use;
22 (b) Ingesting the tablet by any means other than swallowing can result in
23 severe reactions or complications such as blood clots, skin and circula-
24 tory problems, and even death; and
25 (c) No person who takes ritalin after the age of twelve (12) years is
26 eligible for military service.
27 (d) Distribution of the medication to any other person is a felony
28 offense in Idaho and is also a federal offense.
29 (2) The board is authorized and directed to promulgate rules to ensure
30 that the information in subsection (1) of this section is provided by the
31 licensed dispensing pharmacy to each person who takes possession of a ritalin
32 prescription. In addition, the board is responsible for ensuring that the
33 information provided by the licensed dispensing pharmacy is consistent with
34 the most current medical findings.
STATEMENT OF PURPOSE
RS 10943C1
The purpose of this Legislation is to allow the Board of
Pharmacist to broaden the information a patient, parent or
guardian receives when prescribed Methylphendate more commonly
known as Ritalin.
Fiscal Impact
None.
Contact
Name: Rep. John Campbell
Phone: 208-332-1000
STATEMENT OF PURPOSE/FISCAL IMPACT H 21